适应怀孕的YEARS算法:一个回顾性分析
Alden Mileto1, Gina Rossi1, Benjamin Krouse1
1Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania.
The western journal of emergency medicine
|January 11, 2024
概括
适应怀孕的YEARS算法可以安全地减少计算机断层扫描肺血管造影 (CTPA) 在怀孕患者怀疑肺栓塞 (PE) 的使用. 这项在美国进行的验证研究表明,该算法与临床实践保持一致,并减少了成像需求.
科学领域:
- 产科和妇科 产科和妇科
- 放射学 放射学是一门学科.
- 心脏病学 心脏病学
背景情况:
- 肺栓塞 (PE) 是孕妇患病的重要原因之一.
- 目前在怀孕期间对PE的诊断工作缺乏标准化的方法.
- 欧洲研究表明,适应怀孕的YEARS算法可以安全地减少成像.
研究的目的:
- 评估在美国孕妇中使用适应怀孕的YEARS算法来评估CTPA利用率的潜在减少.
- 在美国队列中外部验证适应怀孕的YEARS算法.
主要方法:
- 74名怀孕患者的逆向图表分析,怀疑患有PE.
- 适应怀孕的YEARS算法 (DVT的临床症状,血,PE作为最有可能的诊断,D-二次体).
- 在不需要成像的患者中分析CTPA使用和30天的PE或DVT随访.
主要成果:
- 前列腺炎的患病率为2.7% (2/74名患者).
- 如果应用算法,36名患者将不需要成像;在这个群体中进行了7次CTPA.
- 没有接受初始CTPA的患者在30天内被诊断患有PE或DVT.
结论:
- 适应怀孕的YEARS算法可以减少怀孕患者怀疑PE的CTPA使用.
- 与欧洲研究相比,该算法在成像方面表现出类似的减少.
- 该算法与临床理由的结合表明,该算法有可能被广泛采用.
相关概念视频
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Introduction To Survival Analysis
239
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
239
Kaplan-Meier Approach
146
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
146
Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Assumptions of Survival Analysis
131
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
131


